Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Ulacamten

😃Good
Catalog No. T201288Cas No. 2830607-59-3
Alias CK-586, CK586, CK-4021586, CK4021586

Ulacamten, also known as CK-4021586 or CK-586, is an orally bioavailable and highly selective cardiac myosin inhibitor that enhances the transition of myosin into a force-generating state without altering calcium handling, demonstrating sub-micromolar biochemical potency and improving left ventricular systolic function in preclinical models while maintaining myocardial energetic efficiency and minimizing off-target activity against skeletal and smooth muscle myosin.

Ulacamten

Ulacamten

😃Good
Catalog No. T201288Alias CK-586, CK586, CK-4021586, CK4021586Cas No. 2830607-59-3
Ulacamten, also known as CK-4021586 or CK-586, is an orally bioavailable and highly selective cardiac myosin inhibitor that enhances the transition of myosin into a force-generating state without altering calcium handling, demonstrating sub-micromolar biochemical potency and improving left ventricular systolic function in preclinical models while maintaining myocardial energetic efficiency and minimizing off-target activity against skeletal and smooth muscle myosin.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$667-10 days7-10 days
5 mg$1587-10 days7-10 days
10 mg$2137-10 days7-10 days
25 mg$3967-10 days7-10 days
50 mg$5627-10 days7-10 days
100 mg$7877-10 days7-10 days
200 mg$1,0707-10 days7-10 days
1 mL x 10 mM (in DMSO)$1797-10 days7-10 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Ulacamten, also known as CK-4021586 or CK-586, is an orally bioavailable and highly selective cardiac myosin inhibitor that enhances the transition of myosin into a force-generating state without altering calcium handling, demonstrating sub-micromolar biochemical potency and improving left ventricular systolic function in preclinical models while maintaining myocardial energetic efficiency and minimizing off-target activity against skeletal and smooth muscle myosin.
SynonymsCK-586, CK586, CK-4021586, CK4021586
Chemical Properties
Molecular Weight405.44
FormulaC21H25F2N3O3
Cas No.2830607-59-3
SmilesC(N1C2(C(=O)N(CC1=O)[C@@H]3CC[C@@H](C)CC3)CN(C=O)C2)C4=CC(F)=C(F)C=C4
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 100 mg/mL (246.65 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4665 mL12.3323 mL24.6646 mL123.3228 mL
5 mM0.4933 mL2.4665 mL4.9329 mL24.6646 mL
10 mM0.2466 mL1.2332 mL2.4665 mL12.3323 mL
20 mM0.1233 mL0.6166 mL1.2332 mL6.1661 mL
50 mM0.0493 mL0.2466 mL0.4933 mL2.4665 mL
100 mM0.0247 mL0.1233 mL0.2466 mL1.2332 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Stock solution preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (stock solution concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
The above example illustrates how to use "In Vivo Formulation Calculator" and does not represent a recommended formulation for any specific compound. Please select an appropriate dissolution method based on your experimental animals and route of administration.
All types of co-solvents required for the protocol, such asDMSO, PEG300/ PEG400, Tween 80, SBE-β-CD, corn oil are available for purchase on the TargetMol website with a simple click.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Ulacamten | purchase Ulacamten | Ulacamten cost | order Ulacamten | Ulacamten chemical structure | Ulacamten formula | Ulacamten molecular weight